Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
Bodyl A. Brand, Janna N. de Boer, Machteld Marcelis, et al.
Schizophrenia Bulletin (2023) Vol. 49, Iss. 6, pp. 1579-1590
Open Access | Times Cited: 19

Showing 19 citing articles:

Role of estrogen in sex differences in memory, emotion and neuropsychiatric disorders
Javed Iqbal, Geng-Di Huang, Yanxue Xue, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 17
Estrogen and psychosis — a review and future directions
Eveline Mu, Caroline Gurvich, Jayashri Kulkarni
Archives of Women s Mental Health (2024)
Open Access | Times Cited: 10
Genetic variants in COMT and ESR1 genes shape treatment response to raloxifene in schizophrenia-spectrum disorders
Bodyl A. Brand, Anne Jetske Boer, Janna N. de Boer, et al.
Psychoneuroendocrinology (2025) Vol. 172, pp. 107274-107274
Open Access | Times Cited: 1
Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention
Wenke He, Sen Zhang, Zhengtang Qi, et al.
Pharmacological Research (2024) Vol. 204, pp. 107201-107201
Open Access | Times Cited: 6
Real-World Effectiveness of Menopausal Hormone Therapy in Preventing Relapse in Women With Schizophrenia or Schizoaffective Disorder
Bodyl A. Brand, I. Sommer, Shiral S. Gangadin, et al.
American Journal of Psychiatry (2024)
Closed Access | Times Cited: 5
Single-Cell Transcriptional Profiling Reveals Cell Type-Specific Sex-Dependent Molecular Patterns of Schizophrenia
Rui Zhou, Tianli Zhang, Baofa Sun
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2227-2227
Open Access
Schizophrenia and Related Psychoses

(2025), pp. 1-278
Closed Access
Monitoring the Effectiveness of Treatment in Women with Schizophrenia: New Specialized Cooperative Approaches
M. Natividad, Mary V. Seeman, Jennipher Paola Paolini, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1238-1238
Open Access | Times Cited: 8
Antipsychotic-induced prolactin elevation in premenopausal women with schizophrenia: associations with estrogen, disease severity and cognition
Bodyl A. Brand, Janna N. de Boer, Elske J. M. Willemse, et al.
Archives of Women s Mental Health (2024) Vol. 27, Iss. 6, pp. 931-941
Open Access | Times Cited: 3
Gender differences in clinical and biochemical parameters among patients hospitalized for schizophrenia: towards precision medicine
Cecilia Maria Esposito, F. De Cagna, Alice Caldiroli, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 274, Iss. 5, pp. 1093-1103
Open Access | Times Cited: 7
Disruption of NMDA receptor-mediated regulation of PPI in the maternal immune activation model of schizophrenia is restored by 17β-estradiol and raloxifene
Andrea Gogos, Alyssa Sbisa, Maarten van den Buuse
Schizophrenia Research (2024) Vol. 267, pp. 432-440
Open Access | Times Cited: 2
Maternal immune activation and estrogen receptor modulation induce sex-specific dopamine-related behavioural and molecular alterations in adult rat offspring
Sophie R. Debs, Illya Conn, Brendan Navaneethan, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 236-251
Open Access | Times Cited: 1
Pharmacological Treatments of Negative Symptoms in Schizophrenia—An Update
Eva-Maria Tsapakis, Michael Treiber, Calypso Mitkani, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 18, pp. 5637-5637
Open Access | Times Cited: 1
Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.
Waguih William IsHak, Ashley N. D. Meyer, Luiza Freire, et al.
PubMed (2024) Vol. 21, Iss. 7-9, pp. 27-47
Closed Access | Times Cited: 1
Improving treatment of women with schizophrenia: a review of the recent literature
Alexandre González-Rodríguez, Jesús Cobo, Mary V. Seeman
Exploration of Medicine (2023), pp. 985-1000
Open Access | Times Cited: 2
ANÁLISE DAS TERAPIAS MEDICAMENTOSAS NA CONDUTA DA ESQUIZOFRENIA
Gabrielly Gearola Machado, Eliana Miranda, C. S. Moraes, et al.
Revista Contemporânea (2024) Vol. 4, Iss. 5, pp. e4555-e4555
Open Access
Towards Unequal Care
Bodyl Brand
(2024)
Open Access
Effects of estrogen and raloxifene on synaptic density in the hippocampal CA1 region of ovariectomized rats
Glaucia Mara MenezesdaSilva, Eduardo Carvalho de Arruda Veiga, Manuel de Jesus Simões, et al.
Clinics (2023) Vol. 78, pp. 100312-100312
Open Access | Times Cited: 1
Effects of ketamine on frontoparietal interactions during working memory in macaque monkeys
Liya Ma, Nupur Katyare, Kevin Johnston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top